(Q24239862)

Cochrane Database of Systematic Reviews

inferred from title

venous thromboembolism

1 reference

1 reference

Raza Alikhan

1

0 references

Alexander T Cohen

series ordinal

2

0 references

publication date

8 July 2009

0 references

published in

0 references

cites work

Reduction of mortality in general medical in-patients by low-dose heparin prophylaxis.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003747.PUB2

Clinical effects of anticoagulant therapy in suspected acute myocardial infarction: systematic overview of randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003747.PUB2

Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003747.PUB2

Risk factors for venous thromboembolism in hospitalized patients with acute medical illness: analysis of the MEDENOX Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003747.PUB2

7 January 2021

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003747.PUB2

7 January 2021

Anticoagulants for acute ischaemic stroke

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003747.PUB2

7 January 2021

Extended-duration thromboprophylaxis in acutely ill medical patients with recent reduced mobility: methodology for the EXCLAIM study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003747.PUB2

7 January 2021

Randomized controlled study of heparin and low molecular weight heparin for prevention of deep-vein thrombosis in medical patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003747.PUB2

7 January 2021

Heparin Study in Internal Medicine (HESIM): design and preliminary results

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003747.PUB2

7 January 2021

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003747.PUB2

7 January 2021

The prophylaxis of medical patients for thromboembolism pilot study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003747.PUB2

7 January 2021

Thrombosis prophylaxis in the acutely ill medical patient: insights from the prophylaxis in MEDical patients with ENOXaparin (MEDENOX) trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003747.PUB2

7 January 2021

Venous thromboembolic disease management of the nonsurgical moderate- and high-risk patient

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003747.PUB2

7 January 2021

Benefits of deep-vein thrombosis prophylaxis in the nonsurgical patient: The MEDENOX trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003747.PUB2

7 January 2021

Heparin prophylaxis in bedridden patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003747.PUB2

7 January 2021

Randomised, controlled trial of low-dose heparin for prevention of fatal pulmonary embolism in patients with infectious diseases. The Heparin Prophylaxis Study Group.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003747.PUB2

7 January 2021

Small Subcutaneous Doses of Heparin in Prevention of Venous Thrombosis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003747.PUB2

7 January 2021

Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin. Overview of results of randomized trials in general, orthopedic, and urologic surgery

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003747.PUB2

7 January 2021

A Comparison of Enoxaparin with Placebo for the Prevention of Venous Thromboembolism in Acutely Ill Medical Patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003747.PUB2

7 January 2021

Randomized comparison of enoxaparin with unfractionated heparin for the prevention of venous thromboembolism in medical patients with heart failure or severe respiratory disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003747.PUB2

7 January 2021

Prevention of venous thromboembolism in medical patients with enoxaparin: a subgroup analysis of the MEDENOX study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003747.PUB2

7 January 2021

High risk of the critically ill for venous thromboembolism

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003747.PUB2

7 January 2021

Comparison of sodium and calcium heparin in prevention of venous thromboembolism

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003747.PUB2

7 January 2021

The outcome after treatment of venous thromboembolism is different in surgical and acutely ill medical patients. Findings from the RIETE registry

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003747.PUB2

7 January 2021

Measuring inconsistency in meta-analyses

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003747.PUB2

7 January 2021

Fatal pulmonary embolism in hospitalised patients: a necropsy review

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003747.PUB2

7 January 2021

Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003747.PUB2

7 January 2021

Nadroparin in the prevention of deep vein thrombosis in acute decompensated COPD. The Association of Non-University Affiliated Intensive Care Specialist Physicians of France

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003747.PUB2

7 January 2021

Prevalence and prevention of deep venous thrombosis of the lower extremities in high-risk pulmonary patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003747.PUB2

7 January 2021

Prevention of deep vein thrombosis in medical patients by low-dose heparin

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003747.PUB2

7 January 2021

Autopsy proven pulmonary embolism in hospital patients: are we detecting enough deep vein thrombosis?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003747.PUB2

7 January 2021

Advances in understanding pathogenic mechanisms of thrombophilic disorders

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003747.PUB2

7 January 2021

Rationale and design of a clinical trial of a low-molecular-weight heparin in preventing clinically important venous thromboembolism in medical patients: the prospective evaluation of dalteparin efficacy for prevention of venous thromboembolism in i

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003747.PUB2

7 January 2021

Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003747.PUB2

7 January 2021

Heparins and mechanical methods for thromboprophylaxis in colorectal surgery

1 reference

https://opencitations.net/index/api/v1/references/10.1002/14651858.CD003747.PUB2

Prevention of deep vein thrombosis in elderly medical in-patients by a low molecular weight heparin: a randomized double-blind trial

9 February 2024

1 reference

https://opencitations.net/index/api/v1/references/10.1002/14651858.CD003747.PUB2

The changing pattern of venous thromboembolic disease

9 February 2024

1 reference

https://opencitations.net/index/api/v1/references/10.1002/14651858.CD003747.PUB2

Subcutaneous low-molecular-weight heparin versus standard heparin and the prevention of thromboembolism in medical inpatients. The Heparin Study in Internal Medicine Group.

9 February 2024

1 reference

https://opencitations.net/index/api/v1/references/10.1002/14651858.CD003747.PUB2